Deenanath Mangeshkar Hospital is a large hospital in Pune, India spread over 6 acres with over 900 beds. It is named after the Marathi theatre actor, Natya Sangeet musician and exceptional Hindustani classical vocalist Deenanath Mangeshkar. The first human milk bank in Pune was established at this hospital.

During the past decade, Deenanath Mangeshkar Hospital & Research Centre conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 24 clinical trials were completed, i.e. on average, 51.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deenanath Mangeshkar Hospital & Research Centre" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials sponsored and "Actelion" with 4 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deenanath Mangeshkar Hospital & Research Centre" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Deenanath Mangeshkar Hospital & Research Centre" are "Breast Cancer" (3 trials), "Breast Neoplasms" (3 trials), "Migraine" (3 trials), "Neoplasms" (3 trials) and "Aspergillosis" (2 trials). Many other conditions were trialed in "Deenanath Mangeshkar Hospital & Research Centre" in a lesser frequency.

Most popular intervention types in "Deenanath Mangeshkar Hospital & Research Centre" are "Drug" (69 trials), "Biological" (5 trials), "Other" (4 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Paclitaxel" (4 trials), "placebo" (4 trials), "Lasmiditan" (3 trials) and "pregabalin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Deenanath Mangeshkar Hospital & Research Centre" are 72 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Deenanath Mangeshkar Hospital & Research Centre". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Deenanath Mangeshkar Hospital & Research Centre, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Deenanath Mangeshkar Hospital & Research Centre, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".